Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Raffone

Showing results (11-20 of 235) with videos related to

Pageof 24
Sort By:
Journal of Pediatric and Adolescent Gynecology|August 26, 2024
Hysteroscopic Management of Complete Vaginal and Uterine Septum with Double Cervix: Tips & Tricks for a Safe SurgeryStefano Ferla, Agnese Virgilio, Alessandro Arena, et al.
Pathology Oncology Research : POR|August 25, 2019
Accuracy of One-Step Nucleic Acid Amplification in Detecting Lymph Node Metastases in Endometrial CancerAntonio Raffone, Antonio Travaglino, Angela Santoro, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 21, 2018
PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysisAntonio Travaglino, Antonio Raffone, Gabriele Saccone, et al.
Histopathology|October 23, 2018
Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteriaAntonio Travaglino, Antonio Raffone, Gabriele Saccone, et al.
Pathology Oncology Research : POR|December 8, 2019
TCGA Molecular Subgroups in Endometrial Undifferentiated/Dedifferentiated CarcinomaAntonio Travaglino, Antonio Raffone, Massimo Mascolo, et al.
Journal of Personalized Medicine|December 23, 2022
Integration of Molecular Data in the Prognostic Stratification and Management of Endometrial CarcinomaAntonio Raffone, Antonio Travaglino, Diego Raimondo, et al.
Archives of Gynecology and Obstetrics|February 28, 2019
Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysisAntonio Raffone, Antonio Travaglino, Gabriele Saccone, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 20, 2019
Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysisAntonio Raffone, Antonio Travaglino, Gabriele Saccone, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 1, 2018
Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: A specific marker of precancer and novel indication for treatment: A systematic review and meta-analysisAntonio Travaglino, Antonio Raffone, Gabriele Saccone, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 23, 2019
Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic reviewAntonio Travaglino, Antonio Raffone, Gabriele Saccone, et al.
Pageof 24

Showing results (11-20 of 235) with videos related to

Sort By:
Pageof 24
Journal of Pediatric and Adolescent Gynecology|August 26, 2024
Hysteroscopic Management of Complete Vaginal and Uterine Septum with Double Cervix: Tips & Tricks for a Safe SurgeryStefano Ferla, Agnese Virgilio, Alessandro Arena, et al.
Pathology Oncology Research : POR|August 25, 2019
Accuracy of One-Step Nucleic Acid Amplification in Detecting Lymph Node Metastases in Endometrial CancerAntonio Raffone, Antonio Travaglino, Angela Santoro, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 21, 2018
PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysisAntonio Travaglino, Antonio Raffone, Gabriele Saccone, et al.
Histopathology|October 23, 2018
Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteriaAntonio Travaglino, Antonio Raffone, Gabriele Saccone, et al.
Pathology Oncology Research : POR|December 8, 2019
TCGA Molecular Subgroups in Endometrial Undifferentiated/Dedifferentiated CarcinomaAntonio Travaglino, Antonio Raffone, Massimo Mascolo, et al.
Journal of Personalized Medicine|December 23, 2022
Integration of Molecular Data in the Prognostic Stratification and Management of Endometrial CarcinomaAntonio Raffone, Antonio Travaglino, Diego Raimondo, et al.
Archives of Gynecology and Obstetrics|February 28, 2019
Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysisAntonio Raffone, Antonio Travaglino, Gabriele Saccone, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 20, 2019
Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysisAntonio Raffone, Antonio Travaglino, Gabriele Saccone, et al.
Acta Obstetricia Et Gynecologica Scandinavica|September 1, 2018
Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: A specific marker of precancer and novel indication for treatment: A systematic review and meta-analysisAntonio Travaglino, Antonio Raffone, Gabriele Saccone, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 23, 2019
Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic reviewAntonio Travaglino, Antonio Raffone, Gabriele Saccone, et al.
Pageof 24